Company / Cash per Share
Immunome Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$10.14
FY2025
5-year range
$1.68 / $10.14
FY2021-FY2025
Trend
+205.9%
vs FY2024
Sector context
#18 of 205
Health Care
What the data says
Cash per Share changed +206% YoY in FY2025, a notable deviation from the 6-year average annual change of +135%.
Based on SEC 10-K filings.
10.14 in FY2025 with a 5-year CAGR of -2.9%. Top quartile in the Health Care sector.
Improved from $8.14 to $10.14 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +82.2%
- 5-Year CAGR
- -2.9%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 205This company $10.14 Sector average $67.98
▼
-85.1% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 205.9% year-over-year.
- Ranks #18 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.14 | +205.9% |
| FY2024 | $3.31 | -59.3% |
| FY2023 | $8.14 | +385.5% |
| FY2022 | $1.68 | -60.7% |
| FY2021 | $4.27 | -63.6% |
| FY2020 | $11.73 | +404.7% |
| FY2019 | $2.32 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026